SQI Diagnostics has introduced SQiDlite multiplexing system for pharmaceutical drug development and contract research organizations performing bioanalytical and immunogenicity testing.
The SqiDlite system, which can run on the company's SqiDworks microarray platform, integrates fluidics, washer, dryer, scanner and analyzing functions in a user-friendly bench-top footprint.
SQI Diagnostics CEO Claude Ricks said the company believes that the SQiDlite system's automated, small footprint bench-top platform with total load-and-go capabilities complements its custom assay business.
"With its user-friendly assay development software and LIS interface combined with its ability to significantly reduce cost and labour, SQiDlite is positioned to become a platform of choice for bioanalytics and immunogenicity labs around the world," Ricks added.
The company said it will be exhibiting its automated SQiDlite system at the American Association of Pharmaceutical Scientists (AAPS) Annual Meeting and Exposition being held in Chicago, Illinois, US, until 18 October 2012.